RJ

Ripal Jitendrakumar Prajapati

Active Director Designated Partner DIN 10103515
DIN 10103515 First appointment Apr 2023 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Ripal Jitendrakumar Prajapati

Data last updated:

Ripal Jitendrakumar Prajapati is a Designated Partner at Athilo Lifesciences Llp (since 2023). The company operates in Business Services.

DIN 10103515
Primary Designation Designated Partner
Industry Business Services
First Appointment 06 Apr 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner06 Apr 20232023Active

Board colleagues of Ripal Jitendrakumar Prajapati

NameDINCompanyDesignation
Priya Vikramkumar Chandwani08191141Athilo Lifesciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Athilo Lifesciences Llp
Premium access

Shareholding and investment profile for Ripal Jitendrakumar Prajapati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ripal Jitendrakumar Prajapati

Ripal Jitendrakumar Prajapati currently holds 1 directorship: Athilo Lifesciences Llp (Designated Partner, since 06 Apr 2023).

Ripal Jitendrakumar Prajapati was first appointed on 06 Apr 2023 as Designated Partner at Athilo Lifesciences Llp.

The current boards of Ripal Jitendrakumar Prajapati's companies include Priya Vikramkumar Chandwani (Athilo Lifesciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available